RECOVERY trial: a system for evaluating COVID-19 treatments
-
“randomized, controlled, open-label, adaptive, platform trial comparing a range of possible treatments with usual care in patients hospitalized with COVID-19”
-
Recruits patient participants from those seeking care through the National Health System (NHS) in the UK
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Study design for evaluating 28-day mortality and other clinical outcomes in a randomized controlled trial of Dexamethasone (DEX) among hospitalized COVID-19 patients in RECOVERY trial
Sample size and ending enrollment in evaluating 28-day mortality and other clinical outcomes in a randomized controlled trial of Dexamethasone (DEX) among hospitalized COVID-19 patients in RECOVERY trial
Statistical analysis for evaluating 28-day mortality and other clinical outcomes in a randomized controlled trial of Dexamethasone (DEX) among hospitalized COVID-19 patients in RECOVERY trial
RECOVERY trial: a system for evaluating COVID-19 treatments